The purpose of this study was to determine the pathogenic changes that occur in myoepithelial cells (MECs) from lacrimal glands of a mouse model of Sjögren syndrome. MECs were cultured from lacrimal glands of C57BL/6J [wild type (WT)] and
thrombospondin 1 null (TSP1-/-, alias Thbs1-/-) mice and from mice expressing α-smooth muscle actin-
green fluorescent protein that labels MECs. MECs were stimulated with
cholinergic and α1-adrenergic
agonists, vasoactive intestinal
peptide (VIP), and the
purinergic agonists ATP and
UTP. Then intracellular [Ca2+] was measured using
fura-2, and contraction was observed using live cell imaging. Expression of
purinergic receptors was determined by Western blot analysis, and
mRNA expression was analyzed by microarray. The increase in intracellular [Ca2+]I with VIP and
UTP was significantly smaller in MECs from TSP1-/- compared with WT mice.
Cholinergic agonists,
ATP, and
UTP stimulated contraction in MECs, although contraction of MECs from TSP1-/- mice was reduced compared with WT mice. The amount of
purinergic receptors P2Y1, P2Y11, and P2Y13 was significantly decreased in MECs from TSP1-/- compared with WT mice, whereas several extracellular matrix and
inflammation genes were up-regulated in MECs from TSP1-/- mice. We conclude that lacrimal gland MEC function is altered by
inflammation because the functions regulated by
cholinergic agonists, VIP, and purinergic receptors are decreased in TSP1-/- compared with WT mice.